| Literature DB >> 2120132 |
R Rahner1, A Eckhardt, M Duchêne, H Domdey, B U von Specht.
Abstract
Two monoclonal antibodies (mAbs) designated 2A1 and 6A4 which had been shown to be directed against Pseudomonas aeruginosa outer membrane lipoprotein I were tested in cyclophosphamide treated mice for their protective ability against P. aeruginosa infection. Pretreatment of mice with either 2 mg of 2A1 or 4 mg of 6A4 in combination with lethally irradiated human leucocytes reduced the mortality after subsequent subcutaneous injection of 100 living P. aeruginosa organisms to 50% of the controls. Without leucocytes only mAb 2A1 (isotype IgG2b) showed protection (47%). Irradiated leucocytes alone without mAb did not protect the mice significantly from fatal P. aeruginosa infection.Entities:
Mesh:
Substances:
Year: 1990 PMID: 2120132 DOI: 10.1007/bf01643398
Source DB: PubMed Journal: Infection ISSN: 0300-8126 Impact factor: 3.553